Literature DB >> 2323048

Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate.

J G Dorea1, E Merchan-Hamann, D E Ryan, J Holzbecher.   

Abstract

Leishmaniasis patients were treated with N-methylglucamine antimoniate by intravenous injections of 10 or 20 mg of Sb per kilogram of body weight per day for 10 or 20 days. Digests of skin biopsies taken from the site of lesion before and after treatment were analyzed for antimony by instrumental neutron activation (INAA). The detection limit of the assay was 20 ng, and no Sb could be measured in digests of samples (less than 2.45 mg) taken before treatment. Biopsies taken after injections of Sb showed concentrations in the range of 8.32 to 70.68 ng/g skin. We discuss the usefulness of INAA in the study of Sb in small samples of tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323048

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Skin uptake, distribution, and elimination of antimony following administration of sodium stibogluconate to patients with cutaneous leishmaniasis.

Authors:  M al Jaser; A el-Yazigi; M Kojan; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 2.  Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs.

Authors:  Anke E Kip; Jan H M Schellens; Jos H Beijnen; Thomas P C Dorlo
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

3.  Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice.

Authors:  Samanta Etel Treiger Borborema; João Alberto Osso; Heitor Franco de Andrade; Nanci do Nascimento
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.